BMJ  2008;336:1106-1110 (17 May), doi:10.1136/bmj.39500.677199.AE

Analysis

Rating quality of evidence and strength of recommendations

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

Holger J Schünemann, professor1,2, Andrew D Oxman, researcher3, Jan Brozek, research fellow1, Paul Glasziou, professor4, Roman Jaeschke, clinical professor5, Gunn E Vist, researcher3, John W Williams, Jr, professor6, Regina Kunz, associate professor7, Jonathan Craig, associate professor8, Victor M Montori, associate professor9, Patrick Bossuyt, professor10, Gordon H Guyatt, professor2, for the GRADE Working Group

1 Department of Epidemiology, Italian National Cancer Institute Regina Elena, 00144 Rome, Italy, 2 CLARITY Research Group, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada L8N 3Z5, 3 Norwegian Knowledge Centre for the Health Services, PO Box 7004, 0130 Oslo, Norway, 4 Centre for Evidence-Based Medicine, Department of Primary Health Care, University of Oxford, Oxford OX3 7LF, 5 Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5, 6 Department of Medicine, Duke University and Durham VA Medical Center, Durham, NC 27705, USA, 7 Basel Institute of Clinical Epidemiology, University Hospital Basel, Hebelstrasse 10, 4031 Basel, Switzerland, 8 Screening and Test Evaluation Program, School of Public Health, University of Sydney, Department of Nephrology, Children’s Hospital at Westmead, Sydney, Australia, 9 Knowledge and Encounter Research Unit, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA, 10 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre, University of Amsterdam, Amsterdam 1100 DE, Netherlands

Correspondence to: H J Schünemann schuneh@mcmaster.ca

Analysis, doi: 10.1136/bmj.39490.551019.BEAnalysis, doi: 10.1136/bmj.39489.470347.ADAnalysis, doi: 10.1136/bmj.39493.646875.AE

The GRADE system can be used to grade the quality of evidence and strength of recommendations for diagnostic tests or strategies. This article explains how patient-important outcomes are taken into account in this process

The first 150 words of the full text of this article appear below.


Summary points

As for other interventions, the GRADE approach to grading the quality of evidence and strength of recommendations for diagnostic tests or strategies provides a comprehensive and transparent approach for developing recommendations
Cross sectional or cohort studies can provide high quality evidence of test accuracy
However, test accuracy is a surrogate for patient-important outcomes, so such studies often provide low quality evidence for recommendations about diagnostic tests, even when the studies do not have serious limitations
Inferring from data on accuracy that a diagnostic test or strategy improves patient-important outcomes will require the availability of effective treatment, reduction of test related adverse effects or anxiety, or improvement of patients’ wellbeing from prognostic information
Judgments are thus needed to assess the directness of test results in relation to consequences of diagnostic recommendations that are important to patients


In this fourth article of the five part series, we describe how guideline developers are . . . [Full text of this article]

Testing makes a variety of contributions to patient care


Example question for replacement test

Test accuracy is a surrogate for patient-important outcomes


Using indirect evidence to make inferences about impact on patient-important outcomes


Judgments about quality of underlying evidence


Study design
Study limitations (risk of bias)
Directness

Arriving at a bottom line for study quality


Arriving at a recommendation


Conclusion



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Going from evidence to recommendations
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Yngve Falck-Ytter, Gunn E Vist, Alessandro Liberati, Holger J Schünemann for the GRADE Working Group
BMJ 2008 336: 1049-1051. [Extract] [Full Text] [PDF]

What is "quality of evidence" and why is it important to clinicians?
Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Gunn E Vist, Yngve Falck-Ytter, Holger J Schünemann for the GRADE Working Group
BMJ 2008 336: 995-998. [Extract] [Full Text] [PDF]

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann for the GRADE Working Group
BMJ 2008 336: 924-926. [Extract] [Full Text] [PDF]

Comparative accuracy: assessing new tests against existing diagnostic pathways
Patrick M Bossuyt, Les Irwig, Jonathan Craig, and Paul Glasziou
BMJ 2006 332: 1089-1092. [Full Text] [PDF]

Grading quality of evidence and strength of recommendations
BMJ 2004 328: 1490. [Abstract] [Full Text] [PDF]

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests
Jonathan J Deeks
BMJ 2001 323: 157-162. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Quality of evidence for logical diagnosis and treatment selection
Huw Llewelyn, et al.
bmj.com, 19 May 2008 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview